Does GENB or LMAT pay a bigger dividend?

LMAT pays a dividend (1.17% yield), while GENB has no payments in the available dividend history.

Is GENB or LMAT more profitable?

LMAT runs the higher net margin — GENB at -636.99% versus LMAT at 25.02%.

Generate Biomedicines, Inc. (GENB) vs LeMaitre Vascular, Inc. (LMAT)

A side-by-side comparison of Generate Biomedicines, Inc. and LeMaitre Vascular, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

GENB

Generate Biomedicines, Inc.

$1.78B

$13.87HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

LMAT

LeMaitre Vascular, Inc.

$1.81B

$79.14HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

Total return — GENB vs LMAT

growth of $100 · dividends reinvested · last 1y

GENB +10.0% (+10.0%/yr)LMAT -10.7% (-10.7%/yr)GENB compounded faster over this window

GENB LMAT

GENB vs LMAT: by the numbers

•LMAT is the larger company ($1.81B vs $1.78B market cap).
•LMAT is profitable (25.02% net margin) while GENB runs a net loss (-636.99%).
•LMAT pays a dividend (1.17% yield), while GENB has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	GENB	LMAT
P/E ratio	N/A	27.77
Forward P/E	N/A	27.55
PEG ratio	N/A	1.43
P/S ratio	N/A	6.89
P/B ratio	3.90	4.30
EV / EBITDA	N/A	21.70
FCF yield	N/A	4.08%

Profitability

Metric	GENB	LMAT
Gross margin	100.00%	72.90%
Operating margin	-737.04%	29.46%
Net margin	-636.99%	25.02%
ROE	N/A	15.62%
ROIC	-94.79%	9.81%

Dividends

Metric	GENB	LMAT
Dividend yield	N/A	1.17%
Payout ratio	N/A	33.33%

Growth (annualized)

Metric	GENB	LMAT
Revenue CAGR (5Y)	N/A	11.76%
EPS CAGR (5Y)	N/A	19.42%
FCF CAGR (5Y)	N/A	13.06%
Total return CAGR (5Y)	N/A	9.79%

Frequently asked

Does GENB or LMAT pay a bigger dividend?: LMAT pays a dividend (1.17% yield), while GENB has no payments in the available dividend history.
Is GENB or LMAT more profitable?: LMAT runs the higher net margin — GENB at -636.99% versus LMAT at 25.02%.

Go deeper

Full GENB analysis Full LMAT analysis Interactive comparison tool

Dig into the metrics

LeMaitre Vascular P/E ratio LeMaitre Vascular dividend yield Generate Biomedicines ROE LeMaitre Vascular ROE Generate Biomedicines operating margin LeMaitre Vascular operating margin Generate Biomedicines revenue growth LeMaitre Vascular revenue growth Generate Biomedicines free cash flow LeMaitre Vascular free cash flow

Generate Biomedicines & LeMaitre Vascular appear in these rankings

Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.